A whistleblower lawsuit filed by a former Amgen sales representative has come back to haunt Denver-based dialysis giant DaVita. The Colorado-based company said July 3 that it has agreed to an expected $55 million settlement payment that stems from a claim that there was gross overuse of the Thousand Oaks-based biotech giant’s drugs. Ivey Woodard…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
